Lan Deng

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

Li Xuan, Yu Wang, Fen Huang et al. · The Lancet Oncology · 2020 · 310 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

Ke Zhao, Ren Lin, Zhiping Fan et al. · Journal of Hematology & Oncology · 2022 · 84 citations · Full text

Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial

Hua Jin, Yu Zhang, Sijian Yu et al. · Journal of Hematology & Oncology · 2023 · 65 citations · Full text

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

Li Xuan, Yu Wang, Kaibo Yang et al. · The Lancet Haematology · 2023 · 63 citations

Hematological Malignancy, Oncology, Marrow Transplantation +10

Effect of sorafenib on the outcomes of patients with FLT3‐ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

Li Xuan, Yu Wang, Fen Huang et al. · Cancer · 2018 · 61 citations · Full text